I. Delaet

651 total citations
16 papers, 515 citations indexed

About

I. Delaet is a scholar working on Rheumatology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, I. Delaet has authored 16 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 8 papers in Genetics and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in I. Delaet's work include Rheumatoid Arthritis Research and Therapies (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). I. Delaet is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). I. Delaet collaborates with scholars based in United States, Belgium and Germany. I. Delaet's co-authors include Peter Nash, R. Pappu, Sheila Gujrathi, Rieke Alten, Jeffrey Kaine, Mark C. Genovese, Allison Luo, Edward Keystone, Charles Ludivico and Michael E. Weinblatt and has published in prestigious journals such as Annals of the Rheumatic Diseases, Virology and Trends in Microbiology.

In The Last Decade

I. Delaet

15 papers receiving 490 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
I. Delaet 363 173 152 140 136 16 515
George Vratsanos 519 1.4× 186 1.1× 123 0.8× 296 2.1× 132 1.0× 13 738
Magdalena Herczyńska 288 0.8× 127 0.7× 111 0.7× 124 0.9× 42 0.3× 13 473
Riitta Koivuniemi 260 0.7× 74 0.4× 59 0.4× 110 0.8× 57 0.4× 26 496
J. Eugene Huffstutter 223 0.6× 109 0.6× 58 0.4× 111 0.8× 31 0.2× 15 435
Michael R. Lovy 272 0.7× 89 0.5× 62 0.4× 69 0.5× 52 0.4× 9 392
Manuela Colucci 107 0.3× 142 0.8× 170 1.1× 267 1.9× 55 0.4× 37 763
Krishan Thirunavukkarasu 292 0.8× 142 0.8× 59 0.4× 121 0.9× 24 0.2× 9 430
Chamaida Plasencia 288 0.8× 72 0.4× 58 0.4× 306 2.2× 106 0.8× 29 511
J. Cush 251 0.7× 103 0.6× 47 0.3× 182 1.3× 65 0.5× 16 516
Walter L. Binder 262 0.7× 131 0.8× 22 0.1× 112 0.8× 132 1.0× 24 483

Countries citing papers authored by I. Delaet

Since Specialization
Citations

This map shows the geographic impact of I. Delaet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Delaet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Delaet more than expected).

Fields of papers citing papers by I. Delaet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Delaet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Delaet. The network helps show where I. Delaet may publish in the future.

Co-authorship network of co-authors of I. Delaet

This figure shows the co-authorship network connecting the top 25 collaborators of I. Delaet. A scholar is included among the top collaborators of I. Delaet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Delaet. I. Delaet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Alten, Rieke, Jeffrey Kaine, Edward Keystone, et al.. (2014). Long‐Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment. Arthritis & Rheumatology. 66(8). 1987–1997. 50 indexed citations
2.
Keystone, Edward, Mark C. Genovese, Mark S. Hochberg, et al.. (2013). Prolonged Exposure to Subcutaneous and Intravenous Abatacept in Patients with Rheumatoid Arthritis does not Affect Rates of Infection, Malignancy and Autoimmune Events: Results from Pooled Clinical Trial Data. The Journal of Rheumatology. 40(6). 995–995. 1 indexed citations
3.
Weinblatt, Michael E., Larry W. Moreland, René Westhovens, et al.. (2013). Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program. The Journal of Rheumatology. 40(6). 787–797. 104 indexed citations
4.
5.
Alten, Rieke, Jeffrey Kaine, Edward Keystone, et al.. (2012). Safety profile of subcutaneous abatacept focusing On clinically relevant events in patients with rheumatoid arthritis and up to 4.5 years of exposure. Queensland's institutional digital repository (The University of Queensland). 3 indexed citations
6.
Nash, Peter, Charles Ludivico, I. Delaet, et al.. (2012). Efficacy, safety and pharmacokinetics of subcutaneous abatacept in patients with rheumatoid arthritis, with or without an intravenous loading dose. Lara D. Veeken. 42. 12–12. 4 indexed citations
7.
Keystone, Edward, Joel M. Kremer, Anthony S. Russell, et al.. (2012). Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study. Annals of the Rheumatic Diseases. 71(6). 857–861. 43 indexed citations
8.
9.
Weinblatt, Michael E., Mark C. Genovese, Michael Schiff, et al.. (2012). FRI0191 Immunogenicity is low and transient with intravenous abatacept therapy. Annals of the Rheumatic Diseases. 71. 377–377. 2 indexed citations
10.
Genovese, M. C., G. Léon, Eduardo Mysler, et al.. (2012). FRI0193 SC vs IV abatacept in RA: post-hoc efficacy analysis of long-term acquire (SC) data with aim (IV) data. Annals of the Rheumatic Diseases. 71. 378–378. 2 indexed citations
11.
Kaine, Jeffrey, E. Keystone, Peter Nash, et al.. (2012). AB0567 Safety of SC abatacept in patients with ra: Update from pooled clinical trial data. Annals of the Rheumatic Diseases. 71. 670–670. 5 indexed citations
12.
Léon, G., Eduardo Mysler, M. Keiserman, et al.. (2011). Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate. Arthritis & Rheumatism. 63(10). 2854–2864. 155 indexed citations
13.
Kaine, Jeffrey, Ingrid Strusberg, Ingrid Louw, et al.. (2011). Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). Annals of the Rheumatic Diseases. 71(1). 38–44. 63 indexed citations
14.
Delaet, I. & Albert Boeyé. (1994). Capsid destabilization is required for antibody-mediated disruption of poliovirus. Journal of General Virology. 75(3). 581–587. 8 indexed citations
15.
Boeyé, Albert, et al.. (1994). Antibody neutralization of picornaviruses: can fever help?. Trends in Microbiology. 2(7). 255–257. 6 indexed citations
16.
Delaet, I., R. Vrijsen, & Albert Boeyé. (1992). Antigenic N to H conversion of poliovirus by a monoclonal antibody at low ionic strength. Virology. 188(1). 93–101. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Vratsanos Breakdown of academic impact, for papers by Magdalena Herczyńska Breakdown of academic impact, for papers by Riitta Koivuniemi Breakdown of academic impact, for papers by J. Eugene Huffstutter Breakdown of academic impact, for papers by Michael R. Lovy Breakdown of academic impact, for papers by Manuela Colucci Breakdown of academic impact, for papers by Krishan Thirunavukkarasu Breakdown of academic impact, for papers by Chamaida Plasencia Breakdown of academic impact, for papers by J. Cush Breakdown of academic impact, for papers by Walter L. Binder
Rankless by CCL
2026